Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects

Eitemau Tebyg

• 709. In Vitro Antibacterial Activity and In Vivo Efficacy of Sulbactam–Durlobactam (ETX2514SUL) Against Pathogenic Burkholderia Species
  gan: O’Donnell, John, et al.
  Cyhoeddwyd: (2019)
• Plasma and Intrapulmonary Concentrations of Cefepime and Zidebactam following Intravenous Administration of WCK 5222 to Healthy Adult Subjects
  gan: Rodvold, Keith A., et al.
  Cyhoeddwyd: (2018)
• Pharmacokinetics, Safety, and Tolerability of Intravenous Durlobactam and Sulbactam in Subjects with Renal Impairment and Healthy Matched Control Subjects
  gan: O’Donnell, John, et al.
  Cyhoeddwyd: (2019)
• Intrapulmonary Pharmacokinetics of Levonadifloxacin following Oral Administration of Alalevonadifloxacin to Healthy Adult Subjects
  gan: Rodvold, Keith A., et al.
  Cyhoeddwyd: (2018)
• The Novel β-Lactamase Inhibitor, ETX-2514, in Combination with Sulbactam Effectively Inhibits Acinetobacter baumannii
  gan: Barnes, Melissa D, et al.
  Cyhoeddwyd: (2017)